the Department of Anesthesiology

Left atrial myxoma presenting as pulmonary embolism: potential role of heme oxygenase-1.

Redford DT, Thompson JL, McCulloch JC, Nielsen VG. "Left atrial myxoma presenting as pulmonary embolism: potential role of heme oxygenase-1." Blood Coagul. Fibrinolysis. 2014;25(6):621-4.

Tissue-type plasminogen activator-induced fibrinolysis is enhanced in patients with breast, lung, pancreas and colon cancer.

Nielsen VG, Matika RW, Ley MLB, et al. "Tissue-type plasminogen activator-induced fibrinolysis is enhanced in patients with breast, lung, pancreas and colon cancer." Blood Coagul. Fibrinolysis. 2014;25(3):248-53.

Iron and carbon monoxide enhance coagulation and attenuate fibrinolysis by different mechanisms.

Nielsen VG, Pretorius E. "Iron and carbon monoxide enhance coagulation and attenuate fibrinolysis by different mechanisms." Blood Coagul. Fibrinolysis. 2014;25(7):695-702.

Iron-enhanced coagulation is attenuated by chelation: thrombelastographic and ultrastructural analysis.

Nielsen VG, Pretorius E. "Iron-enhanced coagulation is attenuated by chelation: thrombelastographic and ultrastructural analysis." Blood Coagul. Fibrinolysis. 2014;25(8):845-50.

Old mineshaft, new canary: can circulating osteopontin concentrations predict septic shock?

Nielsen VG. "Old mineshaft, new canary: can circulating osteopontin concentrations predict septic shock?" Minerva Anestesiol. 2015;81(2):116-8.

Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.

Nielsen VG, Garza JI. "Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma." Blood Coagul. Fibrinolysis. 2014;25(8):801-5.

Bariatric patients have plasmatic hypercoagulability and systemic upregulation of heme oxygenase activity.

Nielsen VG, Galvani CA, Boyle PK, Steinbrenner EB, Matika RW. "Bariatric patients have plasmatic hypercoagulability and systemic upregulation of heme oxygenase activity." Blood Coagul. Fibrinolysis. 2015;26(2):200-4.

Heme oxygenase derived carbon monoxide and iron mediated plasmatic hypercoagulability in a patient with calcific mitral valve disease.

Thompson JL, Nielsen VG, Castro AR, Chen A. "Heme oxygenase derived carbon monoxide and iron mediated plasmatic hypercoagulability in a patient with calcific mitral valve disease." J. Thromb. Thrombolysis. 2015;39(4):532-5.

Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide.

Matika RW, Nielsen VG, Steinbrenner EB, Sussman AN, Madhrira M. "Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide." ASAIO J.. 2014;60(6):716-21.

Carbon monoxide and iron modulate plasmatic coagulation in Alzheimer's disease.

Nielsen VG, Pretorius E, Bester J, Jacobsen WK, Boyle PK, Reinhard JP. "Carbon monoxide and iron modulate plasmatic coagulation in Alzheimer's disease." Curr Neurovasc Res. 2015;12(1):31-9.

Pages